8-KThe WireRoutine
Bylaw Amendment
Filed Dec 21, 2022 · 3y ago · Accession 0001193125-22-310054
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Ticker
- BMRN
- CIK
- 1048477
- Form type
- 8-K
- Filing date
- Dec 21, 2022
- Report date
- Dec 15, 2022
- Document
- d440213d8k.htm
- Size
- 428 KB